| Systematic (IUPAC) name | |
|---|---|
| 2-(5-Methoxy-7-methyl-1H-indol-3-yl)-N,N-dimethylethanamine | |
| Clinical data | |
| Pregnancy cat. | ? |
| Legal status | ? |
| Identifiers | |
| CAS number | 61018-77-7 74798-76-8 oxalate salt |
| ATC code | ? |
| PubChem | CID 12338919 |
| ChemSpider | 10578304 |
| ChEMBL | CHEMBL20243 |
| Chemical data | |
| Formula | C14H20N2O |
| Mol. mass | 232.32 g/mol |
| SMILES | eMolecules & PubChem |
|
|
| |
|
5-Methoxy-7,N,N-trimethyltryptamine (5-MeO-7,N,N-TMT, 5-MeO-7-TMT), is a tryptamine derivative which acts as an agonist at the 5-HT2 serotonin receptors.[1][2] In animal tests, both 7,N,N-TMT and 5-MeO-7,N,N-TMT produced behavioural responses similar to those of hallucinogenic drugs such as DMT and 5-MeO-DMT, but compounds with larger 7-position substituents such as 7-ethyl-DMT and 7-bromo-DMT did not produce hallucinogen-appropriate responding despite high 5-HT2 receptor binding affinity, suggesting these may be antagonists or weak partial agonists for the 5-HT2 receptors.[3] The related compound 7-MeO-MiPT (cf. 5-MeO-MiPT) was also found to be inactive, suggesting that the 7-position has poor tolerance for bulky groups at this position, at least if agonist activity is desired.[4]
|
|||||
| This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it. |
This entry is from Wikipedia, the leading user-contributed encyclopedia. It may not have been reviewed by professional editors (see full disclaimer)